Exscientia Company
At Exscientia, we combine the power of AI and human creativity to make safer and more sophisticated drugs available to all. Visit our website to find out more.
Investors
%20.jpg)
%20.jpg)
Connections from
Funding Status:
IPO
Industry:
Pharmatech
Estimated Revenue:
$36.9 million
Technology:
Pharma Tech
Acquisitions Number:
2
Headquarters:
Oxford, Oxfordshire, United Kingdom
Total Funding:
374371987
Last Funding Date:
2021-07-08
Last Funding Type:
Grant
Employee Number:
251-500
Investors Number:
17
Founded Date:
2012-01-01